NASDAQ · Biotechnology

CORT (CORT) Stock

$91.12 -4.45% NASDAQ: CORT Healthcare

Valuation

MetricValue
Price$91.12
Market Cap$9.78B
P/E Ratio146.17
P/B Ratio8.37
P/S Ratio7.14
EPS (TTM)$0.00
52-Week High$96.95
52-Week Low$28.66
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE7.17%
ROA-0.62%
ROCE20.15%
Gross Margin98.25%
Operating Margin-30.08%
Net Margin6.23%
Debt/Equity0.02
Current Ratio2.86

Annual Financials (USD)

Metric20212022202320242025
Revenue$366.0M$402.0M$482.0M$675.0M$761.0M
Operating Profit$124.0M$113.0M$107.0M$137.0M$45.0M
Net Profit$113.0M$101.0M$106.0M$140.0M$100.0M
EPS$0.89$0.87$0.94$1.23$0.82
Op Margin34.0%28.0%22.2%20.3%5.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$424.0M$583.0M$622.0M$841.0M$837.0M
Total Liabilities$48.0M$82.0M$115.0M$161.0M$189.0M
Cash$78.0M$66.0M$136.0M$128.0M$120.0M
Borrowings$1.0M$1.0M$0$7.0M$6.0M

Latest News

CORT: Lowering target price to $95.00 Argus Research · Jul 15, 2026 Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook Motley Fool · Jul 12, 2026 Why Crinetics Stock Soared 99% This Week 24/7 Wall St. · Jul 9, 2026 3 Cash-Heavy Stocks with Questionable Fundamentals StockStory · Jul 7, 2026 3 High-Flying Stocks We Steer Clear Of StockStory · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$168.0M$120.0M$127.0M$198.0M$142.0M
Investing Cash Flow$136.0M$-115.0M$91.0M$-180.0M$70.0M
Financing Cash Flow$-303.0M$-17.0M$-149.0M$-38.0M$-220.0M
Net Cash Flow$1.0M$-11.0M$69.0M$-8.0M$-7.0M
Free Cash Flow$167.0M$120.0M$127.0M$196.0M$142.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.81
EV / EBITDA-744.56
FCF Yield2.18%
Quick Ratio2.77
Interest Coverage—
Return 1Y36.41%
Return 3Y301.22%
Return 5Y370.72%

Ownership

Insiders Held11.54%
Institutions Held75.57%
Institutions Float Held85.43%
Institutional HolderSharesReport Date
Blackrock Inc.12,151,2762026-03-31
Ingalls & Snyder LLC7,608,7162026-03-31
Renaissance Technologies, LLC5,682,7832026-03-31
Vanguard Portfolio Management LLC4,820,5682026-03-31
Vanguard Capital Management LLC4,077,1962026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABVXAbivax S.A. $136.94 +1.50% -24.37 $10.06B 0.00%
AXSM $238.37 -1.09% 38.05 $12.27B 0.00%
CAI $16.45 +2.17% 49.96 $4.65B 0.00%
CYTKCytokinetics, Incorporated $80.62 -0.15% -11.82 $10.03B 0.00%
HALO $81.48 -0.55% 23.58 $9.66B 0.00%

About CORT

CORT is led by CEO Joseph K. Belanoff, employs 730 people, headquartered in Redwood City, US, publicly traded since 2004.

CORT stock trades at $91.12 with a market capitalization of $9.78B. The stock is valued at a price-to-earnings (P/E) ratio of 146.17, price-to-book of 8.37, price-to-sales of 7.14. Over the past 52 weeks the stock has ranged between $28.66 and $96.95, and currently trades 6.0% below its 52-week high.

On profitability, CORT generates a return on equity (ROE) of 7.17%, return on capital employed of 20.15%, an operating margin of -30.08%, a net profit margin of 6.23%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides